FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W54965712> ?p ?o ?g. }

• W54965712 endingPage "84" @default.
• W54965712 startingPage "OL1373" @default.
• W54965712 abstract "The involvement of human papillomavirus in the development of cervical cancer has been firmly established. However, better management of cervical cancer rests on good diagnosis and an effective therapy. In this study we evaluated the frequency of point mutations in epidermal growth factor receptor (EGFR) for future use of tyrosine kinase inhibitors in clinical treatment and to assess the use of EGFR, p16INK4a and E-cadherin as biomarkers in cervical cancer diagnosis with immunohistochemistry. Fifty-three patient specimens of cervical cancer were analysed for HPV infection, for EGFR mutations in exons 18 through 21, and for expression of EGFR, p16INK4a and E-cadherin by immunostaining. Results showed that 79.24% of the cases (42/53) are HPV positive and the HPV types more closely associated with risk are HPV 16 and 18. In all 53 analysed specimens, any mutation affecting the EGFR kinase domain in exons 18 through 21 was observed. Expressions of EGFR, p16INK4a and E-cadherin were detected in 88,67% (47/53), 92,45% (49/53) and 79,24% (42/53) of analysed specimens respectively. Thus, EGFR, p16INK4a and E-cadherin would be excellent tools for IHC analysis during the cervical cancer development. EGFR and p16INK4a can be used for early diagnosis and E-cadherin for cancer progression and cell migration. However, treatment of cervical cancer with TKIs may not be effective and the identification of other EGFR inhibitors is needed." @default.
• W54965712 created "2016-06-24" @default.
• W54965712 creator A5046632543 @default.
• W54965712 creator A5048689896 @default.
• W54965712 creator A5048998883 @default.
• W54965712 creator A5054319007 @default.
• W54965712 creator A5060067026 @default.
• W54965712 creator A5066826172 @default.
• W54965712 creator A5072070917 @default.
• W54965712 date "2010-09-11" @default.
• W54965712 modified "2023-09-27" @default.
• W54965712 title "EGFR, p16INK4a and E-cadherin immuno-histochemistry and EGFR point mutations analyses in invasive cervical cancer specimens from Moroccan women." @default.
• W54965712 cites W1531617031 @default.
• W54965712 cites W1573394606 @default.
• W54965712 cites W1601298699 @default.
• W54965712 cites W1611632861 @default.
• W54965712 cites W1967394241 @default.
• W54965712 cites W1968979312 @default.
• W54965712 cites W1974570262 @default.
• W54965712 cites W1984234749 @default.
• W54965712 cites W1986737605 @default.
• W54965712 cites W1988431769 @default.
• W54965712 cites W1988558796 @default.
• W54965712 cites W1995821713 @default.
• W54965712 cites W1998218812 @default.
• W54965712 cites W2001400232 @default.
• W54965712 cites W2003161561 @default.
• W54965712 cites W2006708542 @default.
• W54965712 cites W2010489316 @default.
• W54965712 cites W2013729017 @default.
• W54965712 cites W2014330130 @default.
• W54965712 cites W2016067272 @default.
• W54965712 cites W2020461527 @default.
• W54965712 cites W2020610780 @default.
• W54965712 cites W2020931531 @default.
• W54965712 cites W2021151163 @default.
• W54965712 cites W2021401697 @default.
• W54965712 cites W2023660230 @default.
• W54965712 cites W2026262319 @default.
• W54965712 cites W2026727845 @default.
• W54965712 cites W2027049659 @default.
• W54965712 cites W2039633811 @default.
• W54965712 cites W2041140757 @default.
• W54965712 cites W2046421136 @default.
• W54965712 cites W2051120695 @default.
• W54965712 cites W2059072983 @default.
• W54965712 cites W2064047613 @default.
• W54965712 cites W2066834338 @default.
• W54965712 cites W2068873956 @default.
• W54965712 cites W2069099757 @default.
• W54965712 cites W2074091932 @default.
• W54965712 cites W2079879369 @default.
• W54965712 cites W2082178103 @default.
• W54965712 cites W2082756312 @default.
• W54965712 cites W2092097855 @default.
• W54965712 cites W2093620760 @default.
• W54965712 cites W2093906223 @default.
• W54965712 cites W2094666432 @default.
• W54965712 cites W2095150828 @default.
• W54965712 cites W2099744746 @default.
• W54965712 cites W2101337755 @default.
• W54965712 cites W2103402872 @default.
• W54965712 cites W2107402652 @default.
• W54965712 cites W2112333900 @default.
• W54965712 cites W2112935959 @default.
• W54965712 cites W2114813165 @default.
• W54965712 cites W2117156908 @default.
• W54965712 cites W2124580184 @default.
• W54965712 cites W2125195105 @default.
• W54965712 cites W2133388337 @default.
• W54965712 cites W2133671622 @default.
• W54965712 cites W2136111158 @default.
• W54965712 cites W2139236349 @default.
• W54965712 cites W2141769927 @default.
• W54965712 cites W2144634347 @default.
• W54965712 cites W2151046736 @default.
• W54965712 cites W2152367439 @default.
• W54965712 cites W2154253360 @default.
• W54965712 cites W2155152706 @default.
• W54965712 cites W2156138698 @default.
• W54965712 cites W2157824687 @default.
• W54965712 cites W2161496449 @default.
• W54965712 cites W2161821474 @default.
• W54965712 cites W2162602627 @default.
• W54965712 cites W2167241562 @default.
• W54965712 cites W2187401003 @default.
• W54965712 cites W2104690803 @default.
• W54965712 cites W284154891 @default.
• W54965712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20937225" @default.
• W54965712 hasPublicationYear "2010" @default.
• W54965712 type Work @default.
• W54965712 sameAs 54965712 @default.
• W54965712 citedByCount "7" @default.
• W54965712 countsByYear W549657122012 @default.
• W54965712 countsByYear W549657122014 @default.
• W54965712 countsByYear W549657122016 @default.
• W54965712 countsByYear W549657122017 @default.
• W54965712 countsByYear W549657122018 @default.

• next